Safety of Natalizumab infusion in multiple sclerosis patients during active SARS-CoV-2 infection.
Landi D, Cola G, Mantero V, Balgera R, Moiola L, Nozzolillo A, Dattola V, Sinisi L, Fantozzi R, Di Lemme S, Centonze D, Mataluni G, Nicoletti CG, Marfia GA.
Landi D, et al. Among authors: centonze d.
Mult Scler Relat Disord. 2022 Jan;57:103345. doi: 10.1016/j.msard.2021.103345. Epub 2021 Oct 24.
Mult Scler Relat Disord. 2022.
PMID: 35158454
Free PMC article.